Meat-Tech 3D Ltd. (TASE: MEAT), a developer of industrial-scale cultivated meat production technologies based on advanced 3D bioprinting, today announces that it has closed a fundraising round of $7 million. Yesterday we reported that the company, already publicly listed in Israel, has filed for IPO in the USA.
Meatech is developing a unique, proprietary bioprinter to deposit layers of cells (including stem cells and differentiated stem cells), scaffolding, and cell nutrients in a three-dimensional form of structured cultured meat, often referred to as cultivated meat and previously widely known as clean meat.
MeaTech’s CEO Sharon Fima commented: “We thank our investors for their confidence in the company’s activities and vision. The investment round enables us to progress the recently announced Peace Of Meat acquisition, strengthening an important part of our R&D and opening up new markets such as that for hybrid products.”
This announcement is made pursuant to, and in accordance with, Rule 135 of the Securities Act of 1933, as amended. This announcement does not, and is not intended to, constitute an offer to sell or a solicitation of an offer to purchase any securities in the United States or elsewhere, and it does not, and is not intended to, constitute an offer, solicitation or sale of any securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful. The information detailed above in this announcement, regarding the Company’s intentions, is “forward-looking” information as defined in the Israeli Securities Law, 1968, and regulations thereunder, based on information known to the Company at this time, as well as forecasts whose fulfillment depends, inter alia, on entities not under the Company’s control as stated above.